Approval · Notice of Compliance 23294 · 2020
ROFACT: Notice of Compliance 23294
Issued March 5, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23294
- Date
- March 5, 2020
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- An additional supplier for the drug substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROFACT | Not yet assigned | — |